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Abstract The mechanism by which the proapoptotic protein
Bax releases cytochrome c from mitochondria is not fully
understood. The present work approaches this problem using
C-terminal truncated oligomeric Bax (BaxvC). Micromolar
concentrations of BaxvC released cytochrome c from isolated
rat heart and liver mitochondria, while the release of adenylate
kinase was not significantly affected. BaxvC also released
cytochrome c but not adenylate kinase from outer membrane
vesicles filled with these proteins. However, BaxvC was
ineffective in releasing cytochrome c when outer membrane
vesicles were obtained in the presence of glycerol, conditions
under which the number of contact sites was drastically reduced.
BaxvC did not liberate encapsulated cytochrome c and adenylate
kinase from pure phospholipid vesicles or vesicles reconstituted
with porin. However, when the hexokinase^porin^adenine
nucleotide translocase complex from brain mitochondria was
reconstituted in vesicles, BaxvC released internal cytochrome c
but not adenylate kinase. In all these systems, only a small
portion of total cytochrome c present in either mitochondria or
vesicles could be liberated by BaxvC. BaxvC also increased the
accessibility of external cytochrome c to either oxidation by
complex IV or reduction by complex III in intact liver and heart
mitochondria. Conclusions : (1) BaxvC selectively releases
cytochrome c and enables a bidirectional movement of cyto-
chrome c across the outer mitochondrial membrane. (2) A
multiprotein complex that resembles the mitochondrial contact
sites is a prerequisite for BaxvC action. (3) A limited pool of
cytochrome c becomes the first target for BaxvC. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
One of the important steps in the process of programmed
cell death, or apoptosis, is the release of several proteins,
including apoptosis-inducing factor (AIF) [1,2] and cyto-
chrome c [3^5], from the mitochondrial intermembrane space
into the cytoplasm. There are several stimuli which cause cy-
tochrome c release. One of them is the proapoptotic Bcl-2
family member Bax (for review see [6]), which is synthesized
in the cytoplasm and translocated to mitochondria [7] where it
releases cytochrome c [8,9].
The mechanism by which Bax releases cytochrome c from
the intermembrane compartment to the cytoplasm is still con-
troversial. In earlier investigations, it has been assumed that
Bax induces mitochondrial permeability transition, leading to
swelling of mitochondria, rupture of the outer membrane and
release of several factors into the cytoplasm [10^13]. However,
recently most researchers agree that the release of cytochrome
c from mitochondria during the initial stage of apoptosis,
mediated by Bax, is a unique process, not related to disrup-
tion of the outer mitochondrial membrane (for reviews see e.g.
[14,15]). The mechanism of this process, its extent, and ki-
netics remain largely controversial. Some authors [12,16,17]
observed a limited release of mitochondrial cytochrome c,
whereas others [18^20] found a massive and rapid release. It
has been found that some cells can recover after cytochrome c
release [19,21] and that the mitochondrial transmembrane po-
tential remains high [8,19,20]. The latter observation strongly
argues for the preservation within the mitochondria of a part
of cytochrome c, su⁄ciently high for undisturbed functioning
of the respiratory chain.
The point of controversy remains whether Bax releases cy-
tochrome c in a speci¢c way or whether it can also enable the
passage of other proteins across the membrane; in other
words, whether Bax may form non-selective pores large
enough for protein tra⁄cking through membranes or its e¡ect
is limited to cytochrome c and, possibly, to other mitochon-
drial proteins participating in apoptosis, like AIF. The ability
of Bax to form pores permeable to small molecules has been
documented for isolated mitochondria independently of the
permeability transition pore [8,9] and for phospholipid bi-
layers [22^26]. Some authors observed that some other pro-
teins located in the mitochondrial intermembrane compart-
ment, like adenylate kinase [13,18,27^30], sul¢te oxidase
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[18], pro-caspase-3 [29] and chaperone proteins [29], are re-
leased along with cytochrome c from mitochondria within
intact cells under conditions that lead to apoptosis or from
isolated mitochondria as e¡ect of Bax action. Another anal-
ogous proapoptotic protein Bid has been shown to liberate
trypsin encapsulated in liposomes [31]. On the other hand,
Doran and Halestrap [16] claim that adenylate kinase is not
released from Bax-containing rat liver mitochondria under
conditions when cytochrome c is released. One of the aims
of the present investigation was therefore to re-examine the
problem of the speci¢city, or its lack, of the release of cyto-
chrome c by the proapoptotic protein Bax.
Another question was whether the release of cytochrome c
from mitochondria is a unidirectional process or whether ex-
ternal cytochrome c can also enter the mitochondrial inter-
membrane compartment. The recovery of some types of cells
after loss of mitochondrial cytochrome c [19,21] indirectly
points to the latter possibility. On the other hand, however,
Kluck et al. [18] observed only a limited accessibility of ex-
ternal cytochrome c to complexes III and IV of the respiratory
chain of Xenopus egg mitochondria in the presence of Bax
unless a cytoplasmic proteinaceous factor, termed ‘permeabil-
ity enhancing factor’, was also present. Doran and Halestrap
[16] described both oxidation of external ferrocytochrome c
and reduction of external ferricytochrome c by rat liver mito-
chondria containing endogenous Bax and have proposed that
permeabilization of the outer membrane to cytochrome c by
Bax is bidirectional. The present results con¢rm that notion
using puri¢ed Bax protein.
Finally, we wanted to approach the problem of whether the
permeabilization of the outer mitochondrial membrane di¡er-
entiates between reduced and oxidized forms of cytochrome c.
Methods of expressing Bax and Bcl-2 in bacteria [22,26]
made available substantial amounts of these proteins and en-
abled to simulate apoptotic conditions in experiments with
isolated mitochondria. Full length Bax is a hydrophobic pro-
tein that requires the presence of detergents in order to be
kept in solution, a condition which presents problems when
studying permeabilization of biological membranes. There-
fore, in the present study we used recombinant truncated
Bax, missing the hydrophobic C-terminal part (BaxvC), that
is soluble in aqueous media without detergent. This modi¢ed
proapoptotic protein has been previously shown [24] to be
qualitatively as e¡ective in releasing cytochrome c as full
length Bax.
2. Materials and methods
2.1. Materials
Oligomeric C-terminal truncated Bax (BaxvC) was prepared as de-
scribed previously [26]. The concentration of the oligomer will be
expressed throughout this paper on the basis of its monomeric mo-
lecular mass of 22 kDa [26]. Bcl-2 was prepared according to the
procedure outlined previously [22]. Porin was isolated from rat liver
mitochondria as described by de Pinto et al. [32]. Cytochrome c from
horse heart and adenylate kinase from rabbit muscle were from Sigma
(St. Louis, MO, USA).
2.2. Isolation of liver and heart mitochondria
Male Wistar rats 3^4 months old were used throughout. The livers
were homogenized in bu¡ered sucrose^mannitol medium containing
EGTA and bovine serum albumin and subjected to di¡erential cen-
trifugation as described previously [33]. Heart mitochondria were iso-
lated essentially as described by Schaller et al. [34] without the trypsin
digestion procedure. In brief, pieces of minced hearts were gently ho-
mogenized in 180 mM KCl+10 mM EDTA (pH 7.4) at 0‡C, the
debris was removed by centrifugation at 600Ug for 3 min, and mi-
tochondria were sedimented and washed (in 180 mM KCl without
EDTA) at 2500Ug for 10 min. Only mitochondrial preparations
with mostly intact outer membranes, assessed by accessibility of the
inner membrane to external cytochrome c [35] not exceeding 10% for
liver and 20% for heart, were used.
2.3. Isolation of the outer mitochondrial membrane and
preparation of outer membrane vesicles
The outer membrane of rat liver mitochondria was isolated accord-
ing to Sottocasa et al. [36] with a subsequent modi¢cation [37] by
disrupting the mitochondria by osmotic shock, hypertonic shrinkage
and mild sonication followed by a discontinuous sucrose density gra-
dient centrifugation. To obtain outer membrane vesicles with en-
trapped cytochrome c, 1.5 mM cytochrome c was added to the shrink-
age^sonication medium. To ¢ll the vesicles with adenylate kinase, the
vesicles collected from the density gradient centrifugation were again
brie£y sonicated in a small volume of the sonication medium contain-
ing about 125 U rabbit muscle adenylate kinase per ml and separated
from the external medium by exclusion chromatography on Sephadex
G-75. Some preparations of the outer membrane vesicles were
obtained in the presence of 30% glycerol in the shrinkage medium
in order to dissociate contact sites between the two mitochondrial
membranes [38].
2.4. Isolation of the hexokinase^porin^adenine nucleotide translocase
(ANT) complex and its reconstitution into liposomes
The hexokinase^porin^ANT complex, displaying properties of the
mitochondrial permeability transition pore [39,40] and considered to
be the core of contact sites between the outer and inner mitochondrial
membranes, was isolated from rat brains as described previously
[39,40]. It was then reconstituted into asolectin vesicles containing
2% cholesterol also as described [39,40]. In brief, the hexokinase-con-
taining fractions were mixed with the liposomes, the remnants of
Triton X-100 were removed by addition of Bio-beads SM-2 (Bio-
Rad) and the mixture was dialyzed overnight against 180 mM
KCl+20 mM HEPES (pH 7.4). Isolated porin was reconstituted in
the same way. To ¢ll the proteoliposomes thus obtained with cyto-
chrome c or adenylate kinase, they were suspended in a small volume
of the medium containing either cytochrome c or adenylate kinase,
brie£y sonicated and separated from the external proteins by chroma-
tography on Sephadex G-75, as described for outer membrane
vesicles.
2.5. Assays for the release of cytochrome c and adenylate kinase
Cytochrome c was measured spectrophotometrically either at
408 nm (Q or Soret band) [24] or, after reduction with ascorbate, at
550 nm (K band) in the supernatants after removal of mitochondria
by centrifugation (2500Ug for 10 min in 1 ml Eppendorf tubes) and
¢ltration through cellulose acetate membranes (0.2 Wm, Iwaki, Japan)
or after removal of outer membrane vesicles or of reconstituted pro-
teoliposomes by centrifugation (400 000Ug for 45 min in 0.7 ml tubes
of a Sorvall RC M100 centrifuge). Adenylate kinase was measured in
the same supernatants in the direction 2 ADPCATP+AMP in a
coupled optical enzyme assay with glucose+hexokinase+NAD+glu-
cose-6-phosphate dehydrogenase (from Leuconostoc mesenteroides ;
Roche, Mannheim, Germany). The determination of succinate dehy-
drogenase activity was performed as described by King [41].
2.6. Oxidation by mitochondria of external added cytochrome c
Oxygen uptake was measured using a Clark-type oxygen electrode
(YSI, Yellow Springs, OH, USA) equipped with a home-made elec-
tronic device to plot the ¢rst derivative of the O2 concentration trace
(equivalent to the O2 uptake rate). Externally added cytochrome c was
maintained in the reduced state by ascorbate.
2.7. Reduction of external added cytochrome c
This was followed spectrophotometrically in a dual wavelength
mode at 550 versus 540 nm (Shimadzu UV-3000 spectrophotometer).
2.8. Statistics
Unless stated otherwise, mean values for at least three experi-
ments þ S.D. are shown in the ¢gures. Statistical signi¢cance was cal-
culated from the Student’s t-test.
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3. Results
3.1. BaxvC facilitates the release of cytochrome c but not of
adenylate kinase from intact heart mitochondria and outer
membrane vesicles
When freshly isolated rat heart mitochondria were incu-
bated at 25‡C in a slightly hyperosmotic saline medium, a
small but detectable amount of cytochrome c, amounting to
0.01% of total cytochrome c, was liberated to the medium
during 30 min, apparently due to a partial damage to the
outer membrane. The release of adenylate kinase was higher
and amounted to about 16% of the total content of this en-
zyme in mitochondria (that could be liberated after hypotonic
swelling or solubilization of mitochondria with digitonin).
This relatively high amount of adenylate kinase released could
be due to the fact that isolated heart mitochondria contained
some adsorbed cytosolic enzyme. BaxvC increased the release
of cytochrome c but not that of adenylate kinase (Fig. 1). Bcl-
2, added in a 1:1 ratio, signi¢cantly suppressed the BaxvC-
dependent cytochrome c liberation.
Selective, though partial, release by BaxvC of cytochrome c
but not of adenylate kinase was also observed in outer mem-
brane vesicles. In this experiment the outer membranes iso-
lated from rat liver mitochondria by the swelling^shrinkage^
sonication procedure form closed vesicles [36]. When the pro-
cedure was performed in the presence of a high concentration
of cytochrome c in the medium, cytochrome c was entrapped
within the vesicles [37]. Similarly as in intact heart mitochon-
dria, the release of cytochrome c from such vesicles was sig-
ni¢cantly increased by BaxvC, and this e¡ect was partly,
though not signi¢cantly, prevented by equimolar Bcl-2 (Fig.
2A, left-hand panel).
Outer membrane vesicles could also be ¢lled with commer-
cially available rabbit muscle adenylate kinase (see Section 2).
BaxvC did not potentiate the release of adenylate kinase from
such vesicles, and no e¡ect was exerted by Bcl-2, either (Fig.
2B).
Some preparations of the outer membrane vesicles were
obtained in the presence of 30% glycerol in order to disrupt
the contact sites between the outer and the inner mitochon-
drial membranes as described previously [38]. In fact, the con-
tent of succinate dehydrogenase, a marker enzyme for the
inner membrane and its remnants in contact sites, was 10 times
lower in the outer membrane fraction isolated in the presence
Fig. 1. E¡ect of BaxvC on the release of cytochrome c and adenylate kinase from rat heart mitochondria. BaxvC and Bcl-2 were used at
7.2 WM each. Other conditions were as described under Section 2. The total amount of cytochrome c in these mitochondrial preparations was
232 þ 6 nmol/mg protein and that of adenylate kinase 447 þ 59 mU/mg protein. *Statistically signi¢cant di¡erence (P6 0.02) with respect to the
control; #statistically signi¢cant di¡erence (P6 0.02) with respect to BaxvC.
Fig. 2. E¡ect of BaxvC on the release of cytochrome c (A) and ade-
nylate kinase (B) from outer membrane vesicles. Outer membrane
vesicles were obtained in the absence or presence of 30% glycerol
and loaded with either cytochrome c or adenylate kinase as de-
scribed under Section 2. Release of the entrapped proteins was mea-
sured after incubation of the vesicles at 25‡C for 30 min in the me-
dium containing 180 mM KCl, 2 mM MgCl2, 0.1 mM CaCl2, and
10 mM Tris^HCl (pH 7.4). 1 WM BaxvC and 1 WM Bcl-2 were
added where indicated. The amount of cytochrome c entrapped
within the vesicles (determined after solubilization with Triton
X-100) amounted to 5000 þ 100 and 4700 þ 60 pmol/mg protein for
vesicles obtained in the absence and in the presence of glycerol, re-
spectively. Hence, the release of cytochrome c from the vesicles pre-
pared in the absence of glycerol (i.e. the di¡erence between the col-
umns designated as ‘Bax’ and ‘Control’) was about 3% of the total
amount of cytochrome c entrapped. *Statistically signi¢cant di¡er-
ence (P6 0.02) with respect to the control.
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of glycerol than in the outer membrane fractions isolated
without glycerol. It was found that the release of cytochrome
c from such vesicles de¢cient in the contact sites was not
increased by BaxvC (Fig. 2A, right-hand panel). Surprisingly,
Bcl-2 alone (not shown) or in combination with BaxvC (Fig.
2) caused some release of both cytochrome c and adenylate
kinase from the vesicles de¢cient in contact sites (obtained in
the presence of glycerol). We have no explanation for this
peculiar behavior. As it is not cytochrome c-speci¢c but also
applies to adenylate kinase, it might be related to pore-form-
ing abilities of Bcl-2 observed in arti¢cial phospholipid mem-
branes at acidic pH [42,43].
3.2. BaxvC releases cytochrome c from liposomes reconstituted
with the hexokinase^porin^ANT complex but not from
those reconstituted with porin alone
Phospholipid liposomes were reconstituted with the hexoki-
nase^porin^ANT complex from brain tissue and loaded with
cytochrome c or adenylate kinase as described under Section
2. From such vesicles, BaxvC partly liberated entrapped cy-
tochrome c but not adenylate kinase (Fig. 3A,B). The libera-
tion of cytochrome c by BaxvC was partly inhibited by Bcl-2
applied at a 1:1 proportion to BaxvC. In contrast, neither
cytochrome c nor adenylate kinase could be released from
phospholipid vesicles reconstituted with porin alone (Fig.
3C,D). Such vesicles were leaky to malate (not shown), indi-
cating that porin was reconstituted in the functionally active
form. Phospholipid vesicles containing neither porin nor the
hexokinase^porin^ANT complex, ¢lled with cytochrome c or
adenylate kinase, did not release the entrapped proteins when
treated with BaxvC (Fig. 3E,F). These results show that
BaxvC does not permeabilize the phospholipid bilayer to cy-
tochrome c, nor that the presence of porin alone is su⁄cient
for BaxvC to induce pores large enough to enable cytochrome
c penetration.
3.3. BaxvC increases the accessibility of external cytochrome c
to the inner mitochondrial membrane in heart and liver
mitochondria.
It has long been known that freshly isolated mitochondria
from liver [35,44], heart muscle [45] and brown adipose tissue
[45] oxidize external ferrocytochrome c only very slowly. In
the present investigation, we showed that external cytochrome
c, kept reduced by the presence of ascorbate, was oxidized
Fig. 3. E¡ect of BaxvC on the release of cytochrome c and adenyl-
ate kinase entrapped within phospholipid vesicles reconstituted with
the hexokinase^porin^ANT complex or with porin alone or from
liposomes containing no reconstituted proteins. The vesicles loaded
with cytochrome c or adenylate kinase were incubated in 180 mM
KCl, 2 mM MgCl2, 0.1 CaCl2 and 20 mM HEPES (pH 7.4) bu¡er
for 30 min at 25‡C. BaxvC and Bcl-2, 0.74 WM each, were present
where indicated. A and B, proteoliposomes reconstituted with the
hexokinase^porin^ANT complex; C and D, proteoliposomes recon-
stituted with porin alone; E and F, liposomes without reconstituted
protein. The total amount of cytochrome c entrapped in the vesicles
was 3100 þ 900 pmol/ml in A and 3450 þ 450 in C and 3100 þ 200 in
E, and that of adenylate kinase 100 þ 5 mU/ml in B, and 180 þ 6
mU/ml in D and F. *Statistically signi¢cant di¡erence (P6 0.005)
with respect to the control; #statistically signi¢cant di¡erence
(P6 0.05) with respect to BaxvC.
Fig. 4. Oxidation (A) and reduction (B) of external cytochrome c by rat liver mitochondria. Mitochondria (1 mg protein/ml in A and 0.33 mg
protein/ml in B) were preincubated at 25‡C in a medium containing 125 mM KCl, 10 mM Tris^HCl (pH 7.4), 1 mM MgCl2, 0.2 mM CaCl2,
0.1 mM cytochrome c and additions speci¢ed below. The reaction was started by adding 1 mM ascorbate (A, oxidation experiments) or 5 mM
succinate (B, reduction experiments). The reaction rate is expressed as percentage of that by mitochondria stripped o¡ the outer membrane by
hypotonic swelling or digitonin treatment [46]. Other additions: A, 4 WM antimycin A and 0.1 mM 2,4-dinitrophenol; B, 2 mM KCN, 5 WM
rotenone and 5 WM carbonyl cyanide m-chlorophenylhydrazone (CCCP). The values in A are means for two mitochondrial preparations and
those in B for three preparations þ S.D.
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very slowly by intact rat liver mitochondria in the medium
containing isotonic KCl. Preincubation of the mitochondria
for 15 min with micromolar BaxvC resulted in a several-fold
increase of the rate of cytochrome c oxidation, amounting to
about 50% of the oxidation rate by mitochondria with com-
pletely disrupted outer membranes (Fig. 4A).
Fig. 4B shows that the reduction rate of external cyto-
chrome c by liver mitochondria was similarly enhanced by
preincubation with BaxvC. In this case electrons were sup-
plied to complex III (via complex II) from succinate and their
passage to molecular oxygen was blocked by cyanide.
BaxvC also increased the rate of oxidation of external cy-
tochrome c by rat heart mitochondria (Fig. 5), although the
stimulation was much lower than in liver mitochondria. This
stimulation was almost completely prevented by Bcl-2 applied
in a two-fold excess with respect to BaxvC (Fig. 5).
4. Discussion
Discussing the results of the present investigation we want
to draw attention to the following aspects: (i) speci¢city of
BaxvC with respect to cytochrome c, (ii) what is the primary
target for Bax, and (iii) the quantitative aspect of cytochrome
c release.
4.1. Speci¢city of BaxvC e¡ect
The present results (Fig. 1) con¢rm the ¢ndings of other
authors [6,8,9,13^15,18,24,47^49] that the proapoptotic pro-
tein Bax promotes a release of cytochrome c from mitochon-
dria. Whether Bax can trigger the release of adenylate kinase,
one of the enzymes present in the intermembrane compart-
ment, has been controversial [16,27^30]. Here we show that
BaxvC does not release adenylate kinase from heart mito-
chondria under conditions where cytochrome c is released.
These results strongly oppose earlier assumptions [10^12]
that the release of cytochrome c and of the AIF at early stages
of apoptosis is preceded by disruption of the outer mitochon-
drial membrane. In addition, we have demonstrated that
BaxvC liberates a part of cytochrome c but not adenylate
kinase from outer mitochondrial membrane vesicles that con-
tain the contact sites (Fig. 2) and from proteoliposomes re-
constituted with the hexokinase^porin^ANT complex (Fig. 3)
in which these proteins have been encapsulated. In accordance
with the known antagonistic e¡ects of Bax and Bcl-2, the
release of cytochrome c by BaxvC was suppressed by Bcl-2.
These results are in line with the observations of Doran and
Halestrap [16] that endogenous Bax under appropriate con-
ditions released a part of cytochrome c, but not of adenylate
kinase, from liver mitochondria.
According to a recent report by Gogvadze et al. [30], cyto-
chrome c can be released from isolated liver mitochondria by
two mechanisms: (i) a Ca2-dependent process, not neces-
sarily connected with large scale mitochondrial swelling, and
(ii) a Ca2-independent release enabled by oligomeric Bax.
However, as pointed out by the same authors, low amounts
of Ca2 may induce opening of the permeability transition
pore in a small subpopulation of mitochondria that is not
depicted by gross swelling and the loss of the membrane po-
tential when measured over the entire population. Hence, a
partial release of cytochrome c and of the intermembrane
isoenzyme of adenylate kinase might be due to disruption of
the outer membrane in this small mitochondrial subpopula-
tion. Nevertheless, Gogvadze et al. [30] observed the release of
adenylate kinase 2, along with cytochrome c, induced by Bax
also in the absence of Ca2 which is in contrast to our results
shown in the present work. This discrepancy may be due to
the fact that these authors used full length Bax, whereas in
our experiments this proapoptotic protein was deprived of its
hydrophobic C-terminal. Both Gogvadze et al. [30] and our-
selves used comparable concentrations of Bax. However, the
truncated protein BaxvC applied in our experiments has a
much lower a⁄nity to membranes than the full length Bax.
4.2. What is the primary target for Bax in the outer
mitochondrial membrane?
Liberation of cytochrome c from the outer membrane
vesicles by BaxvC was observed only when the vesicles con-
tained contact sites. Vesicles obtained in the presence of glyc-
erol, a procedure known to disrupt contact sites [38], appeared
Fig. 5. Oxidation of external cytochrome c by rat heart mitochon-
dria. Mitochondria, 1 mg protein, were suspended in 1.0 ml of a
medium containing 180 mM KCl, 20 mM Tris^HCl (pH 7.4), 1 mM
MgCl2, 0.2 mM CaCl2, 10 WM antimycin A, 5 WM CCCP, 800 U
catalase and 30 WM cytochrome c. The traces represent: A, control
sample; B, mitochondria to which 6 WM BaxvC was added; C, mi-
tochondria to which 6 WM BaxvC and 12 WM Bcl-2 were added
where indicated. Small quantities (0.5 mM) of H2O2 were added
(dashed arrows) to maintain aerobic conditions. Numbers in paren-
theses indicate the rate of O2 uptake in ng atom/min per mg mito-
chondrial protein. Hypotonically swollen mitochondria (full accessi-
bility of the outer membrane to external cytochrome c) respired at
the rate of 270 ng atom O/min per mg protein. This ¢gure repre-
sents one typical experiment out of three.
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not to liberate cytochrome c when incubated with BaxvC
under identical conditions (Fig. 2). The importance of contact
sites for liberation of cytochrome c triggered by Bax was
con¢rmed by experiments with phospholipid vesicles reconsti-
tuted with the hexokinase^porin^ANT complex, previously
shown [39,40] to have properties of native contact sites.
Such proteoliposomes, ¢lled with cytochrome c, liberated
this protein when incubated with BaxvC (Fig. 3A). Proteoli-
posomes reconstituted with porin alone (Fig. 3C) or liposomes
without any reconstituted protein (Fig. 3E) appeared not to
become leaky to encapsulated cytochrome c in the presence of
BaxvC. These results support numerous observations suggest-
ing that Bax does not form cytochrome c-conducting pores by
itself but, rather, interacts with mitochondrial membrane pro-
teins. There are indications that Bax may form cytochrome c-
permeable pores in cooperation with porin in the outer mem-
brane [48,50,51] and ANT in the inner membrane [52,53].
Recently, formation of a large non-selective pore that enables
the passage of cytochrome c across planar phospholipid mem-
branes has been demonstrated by electrophysiological meth-
ods for a full length Bax^porin complex [54]. This is, however,
in contrast to our results showing that low concentrations of
BaxvC produced an out£ow of cytochrome c only in the
presence of the whole hexokinase^porin^ANT complex, thus
suggesting the interaction with mitochondrial contact sites
[55^57]. This point will be subject to further study.
In accordance with other authors [16,18], we found that
Bax enables a bidirectional movement of cytochrome c across
the outer membrane and does not di¡erentiate between its
oxidized and reduced forms.
Our results with protein-free phospholipid vesicles also con-
trast with the observation of Saito et al. [25] who found lib-
eration of cytochrome c from pure phospholipid vesicles by
C-terminal truncated Bax. Whether this di¡erence can be con-
tributed to a di¡erent Bax protein preparation or a di¡erent
lipid composition remains unclear. In the experiments of Saito
et al. [25] liposomes were formed from a phospholipid mixture
containing 30% of the acidic phospholipid, phosphatidic acid,
a composition rather unusual for biological membranes.
4.3. Quantitative aspect of cytochrome c release by Bax
Several authors (e.g. [18^20,30]) observed a complete release
of cytochrome c from mitochondria within the cell under ap-
optotic conditions or from isolated mitochondria under the
action of Bax, whereas we found that only a minute part of
cytochrome c was liberated by low concentrations of BaxvC
from isolated mitochondria (Fig. 1, 7.2 WM), outer membrane
vesicles (Fig. 2, 1 WM) and proteoliposomes reconstituted with
the hexokinase^porin^ANT complex (Fig. 3, 0.74 WM). As
discussed above (Section 4.2), the C-terminal truncated Bax
used in the present study is not embedded within the mem-
brane, as is the case with full length Bax, and might interact
with the membrane by its transmembrane helices 5 and 6. This
type of membrane interaction of BaxvC may be primarily
targeted to a limited portion of cytochrome c that is con¢ned
to the contact sites between the outer and the inner mem-
branes. Interaction of cytochrome c with porin has already
been described by Mannella [58]. In addition, Shimizu et al.
[59] have recently reported that antibodies against porin pre-
vent Bax-induced release of cytochrome c from isolated mito-
chondria. Thus, we want to emphasize that a pool of cyto-
chrome c, limited in size, is particularly sensitive to the action
of Bax. The low concentration of BaxvC used in these experi-
ments did not form unspeci¢c channels. Yet, it was su⁄cient
to mobilize a speci¢c pool of membrane-associated cyto-
chrome c.
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